Meiling Xu, Yuehong Kong, Rongzheng Chen, Pengfei Xing, Junjun Zhang, Xiangrong Zhao, Liyuan Zhang. "RC48-ADC combined with radiotherapy and immunotherapy as salvage therapy for advanced solid tumors with HER2 expression: A multicenter, phase II trial.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.3032